Dec 9, 2021
Results at SABCS show assay has prognostic value that complements value of recurrence score in postmenopausal patients
Dec 3, 2021
Effectively joining SWOG’s work: A how-to for young investigators
Dec 1, 2021
RxPONDER finds postmenopausal women with HR+, HER2- breast cancer with 1-3 involved nodes and an RS of 25 or less can safely skip chemo
Nov 26, 2021
Oct 11, 2021
Oct 1, 2021
Sep 30, 2021
Sep 24, 2021
Adults with cancer in the U.S. gained 14 million years of life from 40 years of NCTN trials.